BiotechTube
Home/Allyx Therapeutics/Stephen Bloch, MD
SB

Stephen Bloch, MD

CEO, Co-Founder

Allyx Therapeutics

Therapeutic Areas

Alzheimer's DiseaseParkinson's DiseaseNeurodegenerative Diseases

Allyx Therapeutics Pipeline

DrugIndicationPhase
ALX-001Alzheimer's DiseasePhase 1b

Leadership Team at Allyx Therapeutics

TS
Timothy Siegert, PhD
COO, Co-Founder
SS
Stephen Strittmatter, MD, PhD
Scientific Founder
View full Allyx Therapeutics profile